Table 6.
HCC (n = 92) | MLC (n = 13) | FNH (n = 13) | Hemangiomas (n = 14) | |
---|---|---|---|---|
Diffuse enhancement | 86 (93.5%) | 4 (30.8%) | 13 (100%) | 0 (0%) |
Nodular enhancement | 0 (0%) | 0 (0%) | 0 (0%) | 13 (92.9%) |
Rim-like enhancement | 6 (6.5%) | 5 (38.4%) | 0 (0%) | 1 (7.1%) |
Non-enhancement | 0 (0%) | 4 (30.8%) | 0 (0%) | 0 (0%) |